why choose us

First received: October 26, 2022

Clinical Trial: (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Breast Neoplasms

Study Type: INTERVENTIONAL


Official Title: A Randomized Phase 2 Non-inferiority Trial of (Z)-Endoxifen and Exemestane + Goserelin as Neoadjuvant Treatment in Premenopausal Women With ER+/HER2- Breast Cancer

Brief Summary: This open-label research study is studying (Z)-endoxifen as a possible treatment for pre-menopausal (still having periods) women with ER+/HER2- breast cancer.(Z)-endoxifen is a selective estrogen receptor modulator or "SERM."SERMs work to treat cancer by blocking the body's natural estrogen from binding to cancer cells.This study includes a pharmacokinetic part (PK, how the drug works in your body) and a treatment part.The primary purpose of the study is to see how (Z)-endoxifen works on tumor…

Read more